Siemens Healthineers launches angiography system, ARTIS icono in India

The angiography system is enabled with significantly superior 2D and 3D imaging, improving image quality, and reducing the radiation required. With an enhanced movement of the C-arm with Sine Spin, the cranial base and skull cap can now be depicted with practically no artifacts in a 3D visualisation. ARTIS icono Biplane will help stroke centres deal with the dual challenge of treating more patients, faster with greater accuracy. Bengaluru: The new ARTIS icono systems adapt flexibly to the differing needs of cardiovascular interventions, interventional radiology, neuroradiology, and vascular interventions. In addition to the multidisciplinary approach, connectivity and digitalisation of interventional labs are becoming increasingly important. The ARTIS icono provides a uniform interface to enable system parameters to be shared easily with devices from other manufacturers with its Third-Party Broker solution.  The system comes with OPTIQ imaging which enables constant image quality regardless of the procedure, patient size, or C-arm angulation. It uses a contrast-driven technique based on automatic parametrisation and intelligent, self-adjusting algorithms ensuring the ALARA dose principle.  The angiography system is enabled with significantly superior 2D and 3D imaging, improving image quality, and reducing the radiation required. With an enhanced movement of the C-arm with Sine Spin, the cranial base and skull cap can now be depicted with practically no artifacts in a 3D visualisation. ARTIS icono Biplane will help stroke centres deal with the dual challenge of treating more patients, faster with greater accuracy.   Sharing her thoughts on this latest development, Sadhana Sheth, Vice President and Head of Advanced Therapies, Siemens Healthineers, India, said, “Stroke patients can now be directly considered for angiography, shortening the lead time before the vascular occlusion is removed. ARTIS icono will thus improve the quality of treatment for patients, therefore expanding the scope of precision medicine to advance therapy options.”